Trimb Healthcare AB has acquired CCS Healthcare AB’s OTC pharmaceutical products in the Nordics. The products are well established in their markets and generate total revenues of approximately €10 million annually.
“Trimb already enjoys strong organic sales growth in the Nordics and in other northern European markets. The acquisition of the CCS portfolio strengthens our position in dermatology and expands our pipeline for the future,” said Magnus Kamryd, CEO of Trimb.
Lindahl assisted Trimb through Malcolm Wiberg, Anders Burén and Anna Tarring.